Lonza Group Ag (LZAGY) Upgraded by Jefferies Group LLC to “Buy”
Lonza Group Ag (OTCMKTS:LZAGY) was upgraded by equities researchers at Jefferies Group LLC from a “hold” rating to a “buy” rating in a research note issued on Wednesday, July 19th, Marketbeat Ratings reports.
Shares of Lonza Group Ag (LZAGY) opened at 23.03 on Wednesday. The firm has a market cap of $14.12 billion, a PE ratio of 37.47 and a beta of 1.05. Lonza Group Ag has a 12-month low of $15.27 and a 12-month high of $24.31. The company has a 50 day moving average price of $22.72 and a 200 day moving average price of $20.21.
Lonza Group Ag Company Profile
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech segment develops and manufactures active pharmaceutical ingredients for life-saving medicines; manufactures commercial bulk drug substance of monoclonal antibodies and recombinant proteins from mammalian cell cultures; and chemical contract manufacturing services, such as microbials, peptides, and small molecules.
Receive News & Stock Ratings for Lonza Group Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group Ag and related stocks with our FREE daily email newsletter.